✅ Suggested content. Review the technical data and compliance, adjust whatever you need and delete this line before publishing.
Semaglutide is an analog of GLP-1, an incretin hormone, designed to be long-acting. It is one of the most studied GLP-1 agonists in the metabolic field. NeoPeptidos offers it as research-grade material, with ≥99% HPLC purity and exclusively for research.
Technical profile
| Product | Semaglutide |
|---|---|
| CAS | 910463-68-2 |
| Molecular formula | C₁₈₇H₂₉₁N₄₅O₅₉ |
| Molecular weight | 4113.58 Da |
| Sequence | Análogo GLP-1 modificado (31 aa) |
| Purity | 99% HPLC |
| Presentation | Lyophilized vial; bacteriostatic water included |
| Use | For scientific research use only |
What is Semaglutide?
GLP-1 is a hormone that takes part in glucose and appetite signaling. Semaglutide is an analog modified to resist degradation and stay active longer, which makes it useful as an experimental tool. It is classified as a long-acting GLP-1 agonist.
Research context
Semaglutide is the subject of extensive metabolic research on glucose homeostasis and body weight regulation in preclinical and clinical studies.
The NeoPeptidos product is research-grade material, not a clinical medicine; it includes no indications or administration schedules and is intended exclusively for researchers.
Handling and reconstitution
See the reconstitution guide and the storage guide.
Quality and traceability
≥99% purity by HPLC and batch COA. See quality control.
🔬 Updated on July 15, 2026 · Reviewed by the NeoPeptidos team · Content for research purposes (RUO).